PRESS RELEASE published on 06/20/2024 at 07:33, 2 years 4 months ago Vallourec prolonge son contrat avec la compagnie pétrolière nationale d'Abu Dhabi et remporte une nouvelle commande Vallourec prolonge son contrat avec la compagnie pétrolière nationale d'Abu Dhabi et remporte une nouvelle commande de tubes et services, renforçant ainsi sa présence sur le marché de l'énergie Vallourec Abu Dhabi Nouvelle Commande Contrat Prolongé Compagnie Pétrolière
PRESS RELEASE published on 06/20/2024 at 07:33, 2 years 4 months ago Vallourec extends its contract with the National Oil Company of Abu Dhabi and wins a new order Vallourec extends contract with National Oil Company of Abu Dhabi, winning new order for 27,000 tonnes of tubes. Contract to expand services and scope. Deliveries from 2024 Contract Extension Oil And Gas Vallourec Abu Dhabi National Oil Company
PRESS RELEASE published on 06/20/2024 at 07:30, 2 years 4 months ago Nordex Group receives orders for 172 MW in Germany Nordex Group secures 172 MW orders in Germany, including 11 N163/6.X turbines for wind farm, with commissioning in 2025. Strong order intake boosts market presence Renewable Energy Germany Nordex Group Wind Farm Repowering Project
PRESS RELEASE published on 06/20/2024 at 07:30, 2 years 4 months ago DEMIRE publishes EPRA Sustainability Report for 2023 – company's CO² emissions significantly lowered DEMIRE Deutsche Mittelstand Real Estate AG reduces corporate CO² emissions by 39% in 2023 as revealed in its EPRA Sustainability Report. Measures include staff engagement and energy efficiency improvements Real Estate CO2 Emissions Sustainability Report DEMIRE EPRA
PRESS RELEASE published on 06/20/2024 at 07:30, 2 years 4 months ago écomiam réalise avec succès une augmentation de capital de 5,3 M EUR pour soutenir son nouveau plan de croissance rentable à moyen terme écomiam annonce une augmentation de capital de 5,3 M€ pour poursuivre son développement. Objectif : créer un réseau de 100 magasins. Principaux investisseurs impliqués Croissance Développement Augmentation De Capital Investisseurs Écomiam
PRESS RELEASE published on 06/20/2024 at 07:30, 2 years 4 months ago Inside Information / Other news releases GenSight Biologics renegotiates financial obligations and provides operational updates, with successful capital increases enhancing short-term flexibility Financial Obligations Operational Updates GenSight Biologics Capital Increases Gene Therapies
PRESS RELEASE published on 06/20/2024 at 07:30, 2 years 4 months ago OSE Immunotherapeutics présente des données précliniques sur sa plateforme ARNm thérapeutique dans le traitement des maladies auto-immunes et inflammatoires au congrès annuel FOCIS, San Francisco (18 – 21 juin) OSE Immunotherapeutics présente des données précliniques sur sa plateforme ARNm thérapeutique au congrès annuel FOCIS à San Francisco. L'IL-35 joue un rôle clé dans le contrôle des maladies auto-immunes et inflammatoires Maladies Auto-immunes OSE Immunotherapeutics ARNm Thérapeutique IL-35 FOCIS
PRESS RELEASE published on 06/20/2024 at 07:00, 2 years 4 months ago Arbonia sells the “Zelgstrasse” site in Arbon to the HRS Group for around CHF 34 million Arbonia AG sells the 'Zelgstrasse' site in Arbon to HRS Group for around CHF 34 million, leading to positive financial effects. The site is fully leased and part of the company's strategy Real Estate Arbonia AG HRS Group Zelgstrasse Arbon
PRESS RELEASE published on 06/20/2024 at 07:00, 2 years 4 months ago Biophytis grants Blanver exclusive rights to BIO101 in Latin America in deal valued at up to €108 Million Biophytis grants Blanver exclusive rights to BIO101 in Latin America in deal valued at up to €108 million. Agreement includes upfront and milestones payments, double-digit royalties, and collaboration on manufacturing and clinical development Biophytis Latin America Exclusive Rights Blanver Pharmaceutical Deal
PRESS RELEASE published on 06/20/2024 at 07:00, 2 years 4 months ago Biophytis accorde à Blanver les droits exclusifs de BIO101 en Amérique Latine dans un accord pouvant atteindre 108 M€ Biophytis accorde à Blanver les droits exclusifs de BIO101 en Amérique Latine dans un accord pouvant atteindre 108 M€. Accord de licence exclusive pour la commercialisation de BIO101, y compris dans l’obésité et les infections respiratoires Biophytis Accord BIO101 Blanver Am\u00e9rique Latine
Published on 10/27/2026 at 17:47, 3 hours 4 minutes ago RecycLiCo and Alaska Energy Metals Collaborate to Test Proprietary Processing Methods on the Polymetallic Eureka Deposit, Nikolai Nickel Project, Alaska
Published on 10/27/2026 at 15:00, 5 hours 51 minutes ago PPX Intercepts High-Grade Gold, Silver, and Copper at Callanquitas, with 13.28 g/t Au, 5,204 g/t Ag and 5.4% Cu Over 1.0 m; and Completes the First Drill Hole at Portachuelos
Published on 10/27/2026 at 14:55, 5 hours 56 minutes ago Sun Valley Minerals Commences Trading on the TSX Venture Exchange; Launches Maiden Drill Program at Tarumán Main
Published on 10/27/2026 at 14:15, 6 hours 36 minutes ago As Ebola Spreads to Multiple Countries, the Importance of NV-387 Oral Gummies Treatment Cannot be Understated - Phase II Clinical Trial Advancing Towards the Second Part, Says NanoViricides
Published on 10/27/2026 at 13:45, 7 hours 6 minutes ago Sekur Private Data Receives US$3.4 Million Per Year Quotation Request from African Government for 1,000 Command Bundle Licenses, 200 SekurOne Accounts and 200 Sekur Tactical Mobile Routers
Published on 10/27/2026 at 20:35, 16 minutes ago Piramal Pharma Limited Announces Results for Q2 and H1 FY27
Published on 10/27/2026 at 19:17, 1 hour 34 minutes ago ZF Finance GmbH : Indicative Maximum Acceptance Amount in relation to the Tender Offer.
Published on 10/27/2026 at 19:11, 1 hour 40 minutes ago Malteries Franco Belges S.A.: Résultats de l'exercice 2025-2026 et mise à disposition du Rapport financier annuel
Published on 10/27/2026 at 18:00, 2 hours 51 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 22, 2026
Published on 10/27/2026 at 18:00, 2 hours 51 minutes ago Nombre total de droits de vote et actions composant le capital social au 22 octobre 2026